https://www.selleckchem.com/products/loxo-195.html
Finally, we identified gene variants in 94.7% of patients analyzed for mutational status with the same implemented capture assay. The prospective application of this technology could simplify clonality assessment and improve standard assay development for leukemia monitoring, as well as provide information about the mutational status of selected leukemia-related genes, potentially representing new prognostic elements, MRD markers, and targets for specific therapies.Inflammatory bowel disease (IBD) is known to significantly increase the
Like
Comment
Share
